Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.74 |
| ▸ | CA12 | O43570 | 2/20 | 0.70 |
| ▸ | CA1 | P00915 | 2/20 | 0.70 |
| ▸ | CA2 | P00918 | 2/20 | 0.70 |
| ▸ | CA9 | Q16790 | 2/20 | 0.70 |
| ▸ | CA7 | P43166 | 1/20 | 0.70 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.70 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.51 |
| ▸ | ABCC9 | O60706 | 3/20 | 0.49 |
| ▸ | ABCC8 | Q09428 | 3/20 | 0.49 |
| ▸ | KCNJ11 | Q14654 | 3/20 | 0.49 |
| ▸ | KCNJ8 | Q15842 | 3/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.49 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.49 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19851420 | 0.84 | MAPT (0.77) | MAPTALDH1A1CA12CA1CA2 | |
| SCHEMBL7733701 | 0.82 | L3MBTL1 (1.00) | MAPTALDH1A1CA12CA1CA2 | |
| SCHEMBL10067644 | 0.82 | CA1 (0.70) | MAPTALDH1A1CA12CA1CA2 | |
| SCHEMBL10603454 | 0.82 | CA1 (1.00) | MAPTALDH1A1CA12CA1CA2 | |
| SCHEMBL28865482 | 0.79 | CA1 (0.67) | MAPTALDH1A1CA12CA1CA2 | |
| SCHEMBL58191 | 0.79 | CA1 (0.67) | MAPTALDH1A1CA12CA1CA2 | |
| SCHEMBL7442584 | 0.79 | CA1 (0.71) | MAPTALDH1A1CA12CA1CA2 | |
| SCHEMBL18613944 | 0.78 | CYP17A1 (0.51) | MAPTALDH1A1CA12CA1CA2 | |
| SCHEMBL28883 | 0.77 | L3MBTL1 (0.79) | MAPTALDH1A1CA12CA1CA2 | |
| SCHEMBL8247039 | 0.77 | ALDH1A1 (0.48) | ALDH1A1CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4414362-A1 | METHOD FOR PRODUCING COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | EA Pharma Co., Ltd. (JP) | 2024-08-14 | — | — | EP | disclosed |
| US-20240262805-A1 | METHOD FOR PRODUCING COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | EA PHARMA CO., LTD. (JP) | 2024-08-08 | — | — | US | disclosed |
| CN-118055925-A | Process for producing compound or pharmaceutically acceptable salt thereof | EA制药株式会社 | 2024-05-17 | — | — | CN | disclosed |
| WO-2023058645-A1 | METHOD FOR PRODUCING COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | ＥＡファーマ株式会社 | 2023-04-13 | — | — | WO | disclosed |
| US-20020128208-A1 | Nonpeptide agonists and antagonists of vasopressin receptors | EMORY UNIVERSITY | 2002-09-12 | — | — | US | disclosed |
| WO-2002047679-A2 | NONPEPTIDE AGONISTS AND ANTAGONISTS OF VASOPRESSIN RECEPTORS | EMORY UNIVERSITY (US) | 2002-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240262805-A1 | METHOD FOR PRODUCING COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, RCC1, REN | MAPT 1560/4885ALDH1A1 3318/4885CA12 950/4885 |
| US-20020128208-A1 | Nonpeptide agonists and antagonists of vasopressin receptors | AVPR1A, AVPR2, AVPR1B | MAPT 4772/4885ALDH1A1 3278/4885CA12 3220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.